Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center studyJonas Willmann, Nicolaus Andratschke, Maiwand Ahmadsei et al.|Radiotherapy and Oncology|2022Cited by 46
Imaging-Based Prevalence of Oligometastatic Disease: A Single-Center Cross-Sectional StudySebastian M. Christ, Matthias Gückenberger, Kaspar Pohl et al.|International Journal of Radiation Oncology*Biology*Physics|2022Cited by 28